Results 231 to 240 of about 19,519 (264)

Nuclear Reactor Safety

Bulletin of the Atomic Scientists, 1974
Joel Primack, Frank Von Hippel
openaire   +1 more source

Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial

Lancet, The, 2020
Feng-Cai Zhu, Wei Chen
exaly  

Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial

Lancet, The, 2020
Feng-Cai Zhu, Zhe Zhang, Jun Zhang
exaly  

Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia

Lancet, The, 2020
Denis Y Logunov, Inna V Dolzhikova, Amir I Tukhvatulin   +2 more
exaly  

Reactor Safety

1980
openaire   +1 more source

Metal–Organic Frameworks for Food Safety

Chemical Reviews, 2019
Lin-Hua Xie, , Hong-Cai Zhou
exaly  

Fast Reactor Safety

Nuclear Science and Engineering, 1972
openaire   +1 more source

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

Lancet, The, 2014
Christian Ruff, Robert P Giugliano, Eugene Braunwald   +2 more
exaly  

The Asymptotic Safety Scenario in Quantum Gravity

Living Reviews in Relativity, 2006
Max Niedermaier
exaly  

Fast Reactor Safety

1971
openaire   +1 more source